INS and Hypoglycemia: The most prominent prescribing issues were related to a lack of clinical knowledge about the appropriate IV fluids to use; the need for prescribing long-acting insulin analogues alongside the VRIII; the need to discontinue other diabetes medicines; and the importance of prescribing IV glucose (for hypoglycaemia).